Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
---|---|---|---|---|---|---|---|---|
2024-05-14 | BIOCRYST PHARMACEUTICALS INC | Thackray Helen M.
(Chief R&D Officer) |
P | Common Stock | A | 30000 | $5.86 - $5.86 | $175,800 |
2023-12-29 | ImmunoGen, Inc. | Wingrove Theresa
(SVP OF REGULATORY AFFAIRS) |
A | Common Stock | A | 615 | $16.01 - $16.01 | $9,846 |
2023-12-19 | BIOCRYST PHARMACEUTICALS INC | Thackray Helen M.
(Chief R&D Officer) |
F | Common Stock | D | 5580 | $6.05 - $6.05 | $33,759 |
A | Grant, award or other acquisition |
C | Conversion of Derivative or Security |
D | Disposition to the issuer of issuer equity securities |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability |
G | Bona fide Gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary Transaction |
J | Other acquisition or disposition |
K | Transaction in equity swap or instrument with similar characteristics |
L | Small Acquisition |
M | Exercise or conversion of derivative security |
O | Exercise of out-of-the-money derivative security |
P | Open Market Purchase |
S | Open Market Sale |
U | Disposition pursuant to a tender of shares in a change of control transaction |
V | Transaction Voluntarily Reported |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |